Helminth control programmes based on preventive chemotherapy against soiltransmitted helminthiases and schistosomiasis are continuing to scale up. In 2021, the global coverage of preventive chemotherapy reached 62.2% for soil-transmitted helminthiases and 40.3% for schistosomiasis; more than 650 million individuals were treated with albendazole and mebendazole for soil-transmitted helminthiases and with praziquantel for schistosomiasis.
The WHO Guidance for Conducting a Country COVID-19 Intra-Action Review (IAR) was developed to guide countries to conduct periodic review(s) of their national and subnational COVID-19 response, so countries do not miss critical opportunities for learning and improvement to better respond to the COVID-19 outbreak in their countries.